3D Medicines, Inc. had a revenue of 209.17M in the quarter ending Jun 30, 2025, with -12.56%. This bring the company's revenue in the last twelve months to 448.39M, Decreased 0.62%. In the fiscal year ending Dec 31, 2024, 3D Medicines, Inc. had annual revenue of 445.65M with -29.81% growth.